These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3029905)

  • 1. Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus: studies on hepatitis and cytomegalovirus markers.
    Nusbacher J; Chiavetta J; Naiman R; Buchner B; Reeves J; Scalia V; Herst R
    Transfusion; 1987; 27(2):207-9. PubMed ID: 3029905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of a confidential method of excluding blood donors exposed to human immunodeficiency virus.
    Nusbacher J; Chiavetta J; Naiman R; Buchner B; Scalia V; Herst R
    Transfusion; 1986; 26(6):539-41. PubMed ID: 3535180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measures to decrease the risk of acquired immunodeficiency syndrome transmission by blood transfusion. Evidence of volunteer blood donor cooperation.
    Pindyck J; Waldman A; Zang E; Oleszko W; Lowy M; Bianco C
    Transfusion; 1985; 25(1):3-9. PubMed ID: 3969698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular biological screening of viruses important to transfusion medicine].
    Wolff C; Hörnschemeyer D; Skurtopulos M; Petersen N; Beyer J; Seidel K; Mutz A; Kleesiek K
    Beitr Infusionsther Transfusionsmed; 1994; 32():102-9. PubMed ID: 9480064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frequency of anti-HBV, CMV, and HTLV antibodies in donors at risk].
    Couroucé AM; Bouchardeau F; Schaffar L
    Rev Fr Transfus Immunohematol; 1984 Sep; 27(4):521-4. PubMed ID: 6095412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of anti-hepatitis B core antigen in hepatitis B virus-vaccinated Chinese blood donors suggests insufficient protection but little threat to the blood supply.
    Zheng X; Ye X; Du P; Zeng J; Zhu W; Yang B; Li C; Allain JP
    Transfusion; 2015 Apr; 55(4):890-7. PubMed ID: 25363504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of mandatory transmissible diseases screening in Indian blood donors.
    Choudhury N; Ramesh V; Saraswat S; Naik S
    Indian J Med Res; 1995 Jun; 101():229-32. PubMed ID: 7672831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients.
    Mosley JW; Stevens CE; Aach RD; Hollinger FB; Mimms LT; Solomon LR; Barbosa LH; Nemo GJ
    Transfusion; 1995 Jan; 35(1):5-12. PubMed ID: 7998069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity.
    Salawu L; Adegoke AO; Aboderin AO; Huraina HA
    West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious disease markers in blood donors in northern Thailand.
    Mundee Y; Kamtorn N; Chaiyaphruk S; Nantachit N; Ness PM; Nelson KE
    Transfusion; 1995 Mar; 35(3):264-7. PubMed ID: 7878721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of viral markers among first-time Arab blood donors in Kuwait.
    Ameen R; Sanad N; Al-Shemmari S; Siddique I; Chowdhury RI; Al-Hamdan S; Al-Bashir A
    Transfusion; 2005 Dec; 45(12):1973-80. PubMed ID: 16371052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-HBc screening of blood donors: a comparison of nine anti-HBc tests.
    Schmidt M; Nübling CM; Scheiblauer H; Chudy M; Walch LA; Seifried E; Roth WK; Hourfar MK
    Vox Sang; 2006 Oct; 91(3):237-43. PubMed ID: 16958836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.
    Barrera JM; Bruguera M; Ercilla MG; Sánchez-Tapias JM; Gil MP; Costa J; Gelabert A; Rodés J; Castillo R
    Ann Intern Med; 1991 Oct; 115(8):596-600. PubMed ID: 1909848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy].
    Kusendová K; Gavorník P; Sabaka P; Sviteková K
    Vnitr Lek; 2016 Jan; 62(1):9-16. PubMed ID: 26967232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value and cost-effectiveness of screening blood donors for antibody to hepatitis B core antigen as a way of detecting window-phase human immunodeficiency virus type 1 infections. The HIV Blood Donor Study Group.
    Busch MP; Dodd RY; Lackritz EM; AuBuchon JP; Birkmeyer JD; Petersen LR
    Transfusion; 1997 Oct; 37(10):1003-11. PubMed ID: 9354817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.